215 related articles for article (PubMed ID: 36087632)
21. Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD "Monaldi care" registry.
Sarubbi B; Colonna D; Correra A; Romeo E; D'Alto M; Palladino MT; Virno S; D'Onofrio A; Russo MG
J Interv Card Electrophysiol; 2022 Mar; 63(2):283-293. PubMed ID: 33709295
[TBL] [Abstract][Full Text] [Related]
22. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
Ishida Y; Payne JE; Field ME; Gold MR
J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
[TBL] [Abstract][Full Text] [Related]
23. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
[TBL] [Abstract][Full Text] [Related]
24. Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry.
Olshansky B; Atteya G; Cannom D; Heidbuchel H; Saarel EV; Anfinsen OG; Cheng A; Gold MR; Müssigbrodt A; Patton KK; Saxon LA; Wilkoff BL; Willems R; Dziura J; Li F; Brandt C; Simone L; Wilhelm M; Lampert R
Heart Rhythm; 2019 Apr; 16(4):581-587. PubMed ID: 30389442
[TBL] [Abstract][Full Text] [Related]
25. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry.
Gulletta S; Gasperetti A; Schiavone M; Vogler J; Fastenrath F; Breitenstein A; Laredo M; Palmisano P; Mitacchione G; Compagnucci P; Kaiser L; Hakmi S; Angeletti A; De Bonis S; Picarelli F; Arosio R; Casella M; Steffel J; Fierro N; Guarracini F; Santini L; Pignalberi C; Piro A; Lavalle C; Pisanò E; Viecca M; Curnis A; Badenco N; Ricciardi D; Dello Russo A; Tondo C; Kuschyk J; Della Bella P; Biffi M; Forleo GB; Tilz R
Heart Rhythm; 2022 Jul; 19(7):1109-1115. PubMed ID: 35257974
[TBL] [Abstract][Full Text] [Related]
26. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B
Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189
[TBL] [Abstract][Full Text] [Related]
27. Transvenous versus subcutaneous implantable cardioverter defibrillators in young cardiac arrest survivors.
Morton MB; Mariani JA; Kistler PM; Patel H; Voskoboinik A
Intern Med J; 2023 Nov; 53(11):1956-1962. PubMed ID: 37929818
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
[TBL] [Abstract][Full Text] [Related]
29. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
30. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
[TBL] [Abstract][Full Text] [Related]
31. Pre-implant predictors of inappropriate shocks with the third-generation subcutaneous implantable cardioverter defibrillator.
Ben Kilani M; Jacon P; Badenco N; Marquie C; Ollitrault P; Behar N; Khattar P; Carabelli A; Venier S; Defaye P
Europace; 2022 Dec; 24(12):1952-1959. PubMed ID: 36002951
[TBL] [Abstract][Full Text] [Related]
32. Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter Trial.
Healey JS; Krahn AD; Bashir J; Amit G; Philippon F; McIntyre WF; Tsang B; Joza J; Exner DV; Birnie DH; Sadek M; Leong DP; Sikkel M; Korley V; Sapp JL; Roux JF; Lee SF; Wong G; Djuric A; Spears D; Carroll S; Crystal E; Hruczkowski T; Connolly SJ; Mondesert B;
Ann Intern Med; 2022 Dec; 175(12):1658-1665. PubMed ID: 36343346
[TBL] [Abstract][Full Text] [Related]
33. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies.
Garnreiter JM; Pilcher TA; Etheridge SP; Saarel EV
Heart Rhythm; 2015 May; 12(5):937-42. PubMed ID: 25620047
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review.
Chue CD; Kwok CS; Wong CW; Patwala A; Barker D; Zaidi A; Mamas MA; Cunnington C; Ahmed FZ
Heart; 2017 Sep; 103(17):1315-1322. PubMed ID: 28687562
[TBL] [Abstract][Full Text] [Related]
35. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
Gold MR; El-Chami MF; Burke MC; Upadhyay GA; Niebauer MJ; Prutkin JM; Herre JM; Kutalek S; Dinerman JL; Knight BP; Leigh J; Lucas L; Carter N; Brisben AJ; Aasbo JD; Weiss R;
J Am Coll Cardiol; 2023 Aug; 82(5):383-397. PubMed ID: 37495274
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators.
Hakamata T; Otsuki S; Izumi D; Sakaguchi Y; Suzuki N; Ikami Y; Hasegawa Y; Yagihara N; Iijima K; Chinushi M; Fuse K; Inomata T
Heart Rhythm; 2022 Oct; 19(10):1704-1711. PubMed ID: 35688344
[TBL] [Abstract][Full Text] [Related]
37. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.
Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R
Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818
[TBL] [Abstract][Full Text] [Related]
38. Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach.
Schneider AE; Burkhart HM; Ackerman MJ; Dearani JA; Wackel P; Cannon BC
Heart Rhythm; 2016 Sep; 13(9):1905-12. PubMed ID: 27321244
[TBL] [Abstract][Full Text] [Related]
39. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
40. Real-world evidence for the use of subcutaneous implantable cardioverter-defibrillators in China: A single-center experience.
Zhang L; Li X; Liang Y; Wang J; Li M; Pan L; Chen X; Qin S; Bai J; Wang W; Su Y; Ge J
Herz; 2023 Dec; 48(6):462-469. PubMed ID: 37540305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
